Illumina (ILMN) shares plummeted 5.28% in pre-market trading on Thursday, reflecting investor concerns following a significant downgrade from a major financial institution.
The sharp decline comes after Barclays lowered its price target on Illumina from $100 to $77, a reduction of 23%. The firm also maintained its Underweight rating on the stock, signaling continued skepticism about Illumina's near-term prospects. This adjustment was part of Barclays' broader first-quarter earnings preview for the sector.
The lowered price target and maintained Underweight rating suggest that Barclays analysts have concerns about Illumina's financial performance or market position. Investors appear to be reacting to this negative outlook, leading to the significant pre-market sell-off. As the market opens, it remains to be seen how Illumina's stock will perform throughout the trading day and whether other analysts will follow suit with similar downgrades.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。